This project aims to establish and expand a biobank of ovarian cancer tissue and blood samples to enhance collaborative research and improve the understanding of ovarian cancer subtypes, their clinical behaviors, and responses to treatment. By collecting and storing patient samples collected during surgery and at various stages of treatment, the biobank will serve as a critical resource for both local and national research collaborations.

The biobank will focus on rare ovarian cancer subtypes, such as clear cell, mucinous, and low-grade serous carcinoma, and will initiate cell cultures to further study these subtypes. The project will also support ongoing tissue processing, storage, and utilization of samples, enabling future studies to gain insights into tumor classification, immunologic behaviors, and the effectiveness of existing and novel therapeutics.